Nyrada Receives A$3.54M R&D Tax Incentive Rebate

Nyrada Inc (ASX: NYR), a drug development company specialising in novel small molecule drugs to treat cardiovascular and neurological diseases today announced it has received a A$3,541,731 cash rebate from the Australian Federal Government’s Research & Development (R&D) tax incentive program.